SMA
Clinical trials for SMA explained in plain language.
Never miss a new study
Get alerted when new SMA trials appear
Sign up with your email to follow new studies for SMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for SMA babies: drug trial aims to boost motor milestones
Disease control Recruiting nowThis study tests a drug called apitegromab in babies under 2 years old who have spinal muscular atrophy (SMA), a genetic condition that weakens muscles. The goal is to see if the drug can improve motor skills like sitting and crawling. All participants must already be on standard…
Matched conditions: SMA
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Swiss database tracks muscle disease patients to boost future treatments
Knowledge-focused Recruiting nowThis study is a registry that collects health information from children and adults in Switzerland who have neuromuscular disorders like SMA, Duchenne, and Becker muscular dystrophy. It does not test a new treatment but gathers data on symptoms, treatments, and quality of life ove…
Matched conditions: SMA
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
French SMA questionnaire put to the test
Knowledge-focused Recruiting nowThis study aims to see if a French version of a questionnaire for adults with spinal muscular atrophy (SMA) gives reliable results when taken twice. About 60 adults with SMA will answer the questionnaire during a regular visit and again 15 days later. The goal is to make sure the…
Matched conditions: SMA
Sponsor: Institut de Myologie, France • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC